Get started
Author

Li Guan

Observed name: Guan, Li
Observed institution: Xi'an Medical University
ORCID: 0000-0001-8514-0122
Observed ORCID: 0000-0001-8514-0122
OpenAlex ID: A5020240642
Design, Synthesis and Biological Evaluation of Quinazoline Derivatives as TXNIP Inhibitors for the Treatment of Type 2 Diabetes Mellitus
2022 · Aiyun Li, Li Guan, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 15
PDF
Design, synthesis, and biological evaluation of β-carboline-cinnamic acid derivatives as DYRK1A inhibitors in the treatment of diabetes
2024 · Li Guan, Aiyun Li, et al. · Bioorganic Chemistry · 9
Discovery of ferulic acid carbamate derivatives as dual-targeting agents of BuChE and Nrf2 for Alzheimer’s disease
2026 · Kejing Lao, Yingze Li, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 4
The optimization of total flavonoids from rhizoma drynariae by response surface methodology and the metal ion chelation activity assay.
2021 · Li Guan, Xingyu Huang, et al. · Pakistan Journal of Pharmaceutical Sciences · 3
Design, synthesis and biological evaluation of quinazoline-carbazole derivatives as dual TXNIP/DYRK1A inhibitors for the treatment of type 2 diabetes mellitus
2026 · Li Guan, Wanzhen Su, et al. · Molecular Diversity
Design, Synthesis and Biological Evaluation of Quinazoline- Carbazole Derivatives as Potent Dual Txnip/Dyrk1a Inhibitors for the Treatment of Type 2 Diabetes Mellitus
2025 · Wanzhen Su, Aiyun Li, et al. · SSRN Electronic Journal
Design, Synthesis and Biological Evaluation of Quinazoline- Carbazole Derivatives as Potent Dual Txnip/Dyrk1a Inhibitors for the Treatment of Type 2 Diabetes Mellitus
2024 · Wanzhen Su, Li Guan, et al. · SSRN Electronic Journal
Works count: 8
Citation count: 31
H-index: 3
I10-index: 1
Year
Topic
Type